Jones Financial Companies
AMLX icon

Jones Financial Companies’s Amylyx Pharmaceuticals AMLX Stock Holding History

Jones Financial Companies’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Buy
597
+327
+121% +$5.06K ﹤0.01% 3764
2026
Q1 		$3.66K Buy
270
+240
+800% +$3.38K ﹤0.01% 3958
2025
Q4 		$362 Hold
30
– – ﹤0.01% 4207
2025
Q3 		$436 Buy
+30
New +$282 ﹤0.01% 4051

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jones Financial Companies's AMLX Position: Q2 2026 in Review

Jones Financial Companies increased its Amylyx Pharmaceuticals (AMLX) stake by 121% in Q2 2026, buying an estimated $5.06K and bringing the position to 597 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3764.

Jones Financial Companies first reported a position in AMLX in Q3 2025 and has held it in 4 quarters since. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Jones Financial Companies held 597 shares of Amylyx Pharmaceuticals worth $10.6K as of Q2 2026.
  • Jones Financial Companies bought 327 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $5.06K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3764 holding.
  • Jones Financial Companies first reported a position in Amylyx Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.